NCT05311696 is a clinical trial of psychoeducation in PTSD, sponsored by Valhalla Project Niagara.

Who is sponsoring NCT05311696?

NCT05311696 is sponsored by Valhalla Project Niagara.

What drugs are being tested in NCT05311696?

Interventions in NCT05311696: psychoeducation.

Is NCT05311696 still recruiting?

NCT05311696 is currently status unknown. Last updated 5 April 2022.

Last reviewed 2022-04-05 · How we verify

NCT05311696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Residential Retreat for Veterans and First-responders

Status unknown Last updated 5 April 2022

What this trial tests

trial testing psychoeducation in PTSD in 70 participants. Status unknown.

Timeline

27 March 2022

Primary endpoint
21 November 2022

21 November 2023

Quick facts

Lead sponsor	Valhalla Project Niagara
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	70
Start date	27 March 2022
Primary completion	21 November 2022
Estimated completion	21 November 2023
Sites	1 location across Canada

Drugs / interventions tested

psychoeducation

Conditions studied

PTSD — all drugs for PTSD →

Sponsor

Valhalla Project Niagara

Who can join

18 and older, any sex, with PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the potential efficacy and feasibility of a residential retreat program to address PTSD symptoms in Veterans and First-responders

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of psychoeducation

Trials testing the same drug.

NCT06868602 — Effects of Regular Exercise and Psychoeducation on Quality of Life and Depression in the Treatment of Sarcopenia · NA · completed
NCT06496399 — Evaluation of the Psychoeducation Program Given to the Elderly Living Alone at Home in Terms of Some Parameters · NA · recruiting
NCT06536205 — Acceptance-commitment Therapy-based Psychoeducation for Individuals Experiencing Earthquakes · NA · active not recruiting
NCT06326515 — Cognitive Behavior Therapy for Depression, Stigmatization, Criminogenic Cognition, and Quality of Life Among Patients Wi · NA · unknown
NCT07189767 — Effects of Psychoeducation on Pregnant Women With Traumatic Birth Perception · NA · completed

Other recruiting trials for PTSD

Currently open trials in the same condition.

NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05311696 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Valhalla Project Niagara
Last refreshed: 5 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05311696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing